Balyasny Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-86,573
| Closed | -$2.94M | – | 1981 |
|
|
2024
Q3 | $2.94M | Buy |
+86,573
| New | +$2.94M | ﹤0.01% | 1008 |
|
|
2024
Q2 | – | Sell |
-64,769
| Closed | -$2.72M | – | 1983 |
|
|
2024
Q1 | $2.72M | Buy |
64,769
+40,650
| +169% | +$1.71M | ﹤0.01% | 1020 |
|
|
2023
Q4 | $957K | Sell |
24,119
-3,296
| -12% | -$131K | ﹤0.01% | 1223 |
|
|
2023
Q3 | $754K | Buy |
+27,415
| New | +$754K | ﹤0.01% | 1211 |
|
|
2022
Q2 | – | Sell |
-61,240
| Closed | -$2.09M | – | 2343 |
|
|
2022
Q1 | $2.09M | Buy |
61,240
+53,878
| +732% | +$1.84M | 0.01% | 1042 |
|
|
2021
Q4 | $284K | Buy |
+7,362
| New | +$284K | ﹤0.01% | 1527 |
|
|
2018
Q2 | – | Sell |
-5,187
| Closed | -$181K | – | 1622 |
|
|
2018
Q1 | $181K | Buy |
5,187
+3,147
| +154% | +$110K | ﹤0.01% | 1584 |
|
|
2017
Q4 | $87K | Sell |
2,040
-1,053
| -34% | -$44.9K | ﹤0.01% | 1738 |
|
|
2017
Q3 | $133K | Buy |
+3,093
| New | +$133K | ﹤0.01% | 1547 |
|
|
2015
Q3 | – | Sell |
-3,720
| Closed | -$1.41M | – | 994 |
|
|
2015
Q2 | $1.41M | Buy |
+3,720
| New | +$1.41M | 0.01% | 551 |
|
|
2013
Q3 | – | Sell |
-18,333
| Closed | -$4.29M | – | 431 |
|
|
2013
Q2 | $4.29M | Buy |
+18,333
| New | +$4.29M | 0.07% | 244 |
|